Anthem Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Okay. Good afternoon, and welcome to the continuation of day 1 of the Barclays Global Healthcare Conference. I'm Steven Valiquette, the health care services analyst here at Barclays.
Our next session will be with Anthem. With us from the company today, we have John Gallina, the company's CFO. We also have Jeff Alter, who's the EVP of the IngenioRx PBM operations, and Steve Tanal from Investor Relations as well.
So this will be a fireside chat. So I'm going to just start with a high-level question, then I'll hit a few on the PBM since Jeff is here. And then we'll dive into more of the core health benefit operations after that.
So welcome, guys. Obviously, you had your Analyst Day last week where you provided a lot of color on the 12% to 15% growth outlook that is now expected to continue through 2025. That's certainly helpful. Before we dive into the outlook of all that by business segment, the company did spend a lot of time talking about how the digital platform is going to be a big driver of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |